ENTA
Enanta Pharmaceuticals Inc
Price:  
6.59 
USD
Volume:  
259,534.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA Relative Valuation

-1077.3%
Upside

As of 2025-07-16, the Relative Valuation of Enanta Pharmaceuticals Inc (ENTA) is (64.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.59 USD, the upside of Enanta Pharmaceuticals Inc based on Relative Valuation is -1077.3%.

The range of the Relative Valuation is (53.78) - (75.23) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.1x - 23.9x 18.2x
Forward P/E multiples 14.3x - 20.1x 16.2x
Fair Price (53.78) - (75.23) (64.41)
Upside -916.0% - -1241.5% -1077.3%
6.59 USD
Stock Price
(64.41) USD
Fair Price

ENTA Relative Valuation - Historical P/E Data

Date P/E
2025-07-11 -1.75
2025-07-10 -1.86
2025-07-09 -1.90
2025-07-08 -2.07
2025-07-07 -2.04
2025-07-03 -2.10
2025-07-02 -2.13
2025-07-01 -2.05
2025-06-30 -2.02
2025-06-27 -2.00
2025-06-26 -2.00
2025-06-25 -1.99
2025-06-24 -1.95
2025-06-23 -1.90
2025-06-20 -1.91
2025-06-18 -1.93
2025-06-17 -1.88
2025-06-16 -1.94
2025-06-13 -2.00
2025-06-12 -1.98
2025-06-11 -2.12
2025-06-10 -2.02
2025-06-09 -2.00
2025-06-06 -1.99
2025-06-05 -1.92
2025-06-04 -1.90
2025-06-03 -1.92
2025-06-02 -1.68
2025-05-30 -1.58
2025-05-29 -1.64
2025-05-28 -1.57
2025-05-27 -1.55
2025-05-23 -1.55
2025-05-22 -1.53
2025-05-21 -1.54
2025-05-20 -1.62
2025-05-19 -1.59
2025-05-16 -1.53
2025-05-15 -1.43
2025-05-14 -1.38
2025-05-13 -1.39
2025-05-12 -1.48
2025-05-09 -1.41
2025-05-08 -1.42
2025-05-07 -1.35
2025-05-06 -1.35
2025-05-05 -1.45
2025-05-02 -1.59
2025-05-01 -1.61
2025-04-30 -1.62